Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael A Überall. (2020) A Review of Scientific Evidence for THC:CBD Oromucosal Spray (Nabiximols) in the Management of Chronic Pain. Journal of Pain Research 13, pages 399-410.
Read now
Read now
Articles from other publishers (23)
Sitthiphon BunmanSombat Muengtaweepongsa, Dilok PiyayotaiRatthaphol CharlermrojKorawit KanjanaSudtida Kaew-amdeeManlika MakornwattanaSanghyun Kim. (2023) Analgesic and Anti-Inflammatory Effects of 1% Topical Cannabidiol Gel in Animal Models. Cannabis and Cannabinoid Research.
Crossref
Crossref
Brittney R. Lins, Chidozie C. Anyaegbu, Sarah C. Hellewell, Melissa Papini, Terence McGonigle, Luca De Prato, Matthew Shales & Melinda Fitzgerald. (2023) Cannabinoids in traumatic brain injury and related neuropathologies: preclinical and clinical research on endogenous, plant-derived, and synthetic compounds. Journal of Neuroinflammation 20:1.
Crossref
Crossref
Ehsan Motaghi, Masoumeh Ghasemi-Pirbaluti, Mohsen Rashidi, Masoud Alasvand, Patricia Di Ciano & Hooman Bozorgi. (2023) The effect of tetrahydrocannabinol:cannabidiol oromucosal spray on cognition: a systematic review. European Journal of Clinical Pharmacology.
Crossref
Crossref
Barbara Vuic, Tina Milos, Lucija Tudor, Marcela Konjevod, Matea Nikolac Perkovic, Maja Jazvinscak Jembrek, Gordana Nedic Erjavec & Dubravka Svob Strac. (2022) Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential. Biomedicines 10:12, pages 3000.
Crossref
Crossref
P. Oikonomou & W. H. Jost. (2022) Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review. Journal of Neural Transmission 129:10, pages 1247-1256.
Crossref
Crossref
Erin Leach, Larissa B. Fomum Mugri, Man Yee Keung, Lindsey Ouellette, Tiffany Fleeger, Thomas Sapp, Justin Houseman, Megan Hamilton & Jeffrey S. Jones. (2022) Neuropsychiatric effects of cannabis toxicity in the emergency department: A community-based study. The American Journal of Emergency Medicine 56, pages 375-377.
Crossref
Crossref
Nicholas Dopkins, Kathryn Miranda, Kiesha Wilson, Bryan L. Holloman, Prakash Nagarkatti & Mitzi Nagarkatti. (2021) Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis. Journal of Neuroimmune Pharmacology 17:1-2, pages 15-32.
Crossref
Crossref
Fatma Haddad, Ghadeer Dokmak & Rafik Karaman. (2022) The Efficacy of Cannabis on Multiple Sclerosis-Related Symptoms. Life 12:5, pages 682.
Crossref
Crossref
Michelle Sexton, Jose M Garcia, Aminah Jatoi, Carey S Clark & Mark S Wallace. (2021) The Management of Cancer Symptoms and Treatment-Induced Side Effects With Cannabis or Cannabinoids. JNCI Monographs 2021:58, pages 86-98.
Crossref
Crossref
Andrea Valeri & Emanuela Mazzon. (2021) Cannabinoids and Neurogenesis: The Promised Solution for Neurodegeneration?. Molecules 26:20, pages 6313.
Crossref
Crossref
Mathew P Caputo, Carmen S Rodriguez, Tapan A Padhya & Matthew J Mifsud. (2021) Medical Cannabis as Adjunctive Therapy for Head and Neck Cancer Patients. Cureus.
Crossref
Crossref
Zinah Zamil Al-Ghezi, Philip Brandon Busbee, Hasan Alghetaa, Prakash S. Nagarkatti & Mitzi Nagarkatti. (2019) Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome. Brain, Behavior, and Immunity 82, pages 25-35.
Crossref
Crossref
Christina A. Brezing & Frances R. Levin. 2019. Cannabis Use Disorders. Cannabis Use Disorders
201
205
.
Kathy T. Vo, Howard Horng, Kai Li, Raymond Y. Ho, Alan H.B. Wu, Kara L. Lynch & Craig G. Smollin. (2018) Cannabis Intoxication Case Series: The Dangers of Edibles Containing Tetrahydrocannabinol. Annals of Emergency Medicine 71:3, pages 306-313.
Crossref
Crossref
Christina A Brezing & Frances R Levin. (2017) The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology 43:1, pages 173-194.
Crossref
Crossref
Douglas L Boggs, Jacques D Nguyen, Daralyn Morgenson, Michael A Taffe & Mohini Ranganathan. (2017) Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol. Neuropsychopharmacology 43:1, pages 142-154.
Crossref
Crossref
Guillermo Izquierdo. (2017) Multiple sclerosis symptoms and spasticity management: new data. Neurodegenerative Disease Management 7:6s, pages 7-11.
Crossref
Crossref
Katarzyna Starowicz & David P. Finn. 2017. Cannabinoid Pharmacology. Cannabinoid Pharmacology
437
475
.
Linda Anh Nguyen & Linda Lee. 2017. Nausea and Vomiting. Nausea and Vomiting
165
173
.
Marie Fitzgibbon, David P. Finn & Michelle Roche. (2016) High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity. International Journal of Neuropsychopharmacology 19:3, pages pyv095.
Crossref
Crossref
James S. Brodie, Vincenzo Di Marzo & Geoffrey W. Guy. (2015) Polypharmacology Shakes Hands with Complex Aetiopathology. Trends in Pharmacological Sciences 36:12, pages 802-821.
Crossref
Crossref
William G. Notcutt. (2015) Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis. Neurotherapeutics 12:4, pages 769-777.
Crossref
Crossref
Y. S. Sakin, A. Dogrul, F. Ilkaya, M. Seyrek, U. H. Ulas, M. Gulsen & S. Bagci. (2015) The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents. Neurogastroenterology & Motility 27:7, pages 936-944.
Crossref
Crossref